AstraZeneca PLC is 1.0x more valuable than Novartis AG by market capitalization ($286.27 B vs $283.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AZN | NVS |
|---|---|---|
| Market cap | $286.27 B | $283.13 B |
| US-listed rank | #45 | #47 |
| SEC filings | 1,004 | 947 |
AstraZeneca PLC is 1.0x more valuable than Novartis AG by market capitalization ($286.27 B vs $283.13 B).
Full pages: AstraZeneca PLC and Novartis AG, or browse the full rankings.